EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling
dc.contributor.author | DeHaan, Alyse M. | en_US |
dc.contributor.author | Wolters, Natalie M. | en_US |
dc.contributor.author | Keller, Evan T. | en_US |
dc.contributor.author | Ignatoski, Kathleen M. Woods | en_US |
dc.date.accessioned | 2009-03-03T20:09:49Z | |
dc.date.available | 2010-05-07T17:40:09Z | en_US |
dc.date.issued | 2009-04-01 | en_US |
dc.identifier.citation | DeHaan, Alyse M.; Wolters, Natalie M.; Keller, Evan T.; Ignatoski, Kathleen M. Woods (2009). "EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling." The Prostate 69(5): 528-537. <http://hdl.handle.net/2027.42/61882> | en_US |
dc.identifier.issn | 0270-4137 | en_US |
dc.identifier.issn | 1097-0045 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/61882 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=19143022&dopt=citation | en_US |
dc.description.abstract | BACKGROUND Bone metastasis occurs frequently in advanced prostate cancer (PCa) patients; however, it is not known why this happens. The epidermal growth factor receptor (EGFR) ligand EGF is available to early stage PCa; whereas, TGF-Α is available when PCa metastasizes. Since the microenvironment of metastases has been shown to play a role in the survival of the tumor, we examined whether the ligands had effects on cell survival and proliferation in early and late PCa. METHODS We used LNCaP cells as a model of early stage, non-metastatic PCa and the isogenic C4-2B cells as a model of late stage, metastatic PCa. RESULTS We found that the proliferation factor MAPK and the survival factor AKT were differentially activated in the presence of different ligands. TGF-Α induced growth of C4-2B cells and not of the parental LNCaP cells; however, LNCaP cells expressing a constitutively active AKT did proliferate with TGF-Α. Therefore, AKT appeared to be the TGF-Α-responsive factor for survival of the late stage PCa cells. LNCaP cells exposed to EGF produced more osteoprotegerin (OPG), an inhibitor of bone remodeling, than C4-2B cells with TGF-Α, which had increased expression of RANKL, an activator of bone remodeling. In concordance, TGF-Α-treated C4-2B conditioned medium was able to differentiate an osteoclast precursor line to a greater extent than EGF-treated C4-2B or TGF-Α-treated LNCaP conditioned media. CONCLUSION The switch in EGFR ligand availability as PCa progresses affects cell survival and contributes to bone remodeling. Prostate 69:528–537, 2009. © 2009 Wiley-Liss, Inc. | en_US |
dc.format.extent | 317241 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.subject.other | Life and Medical Sciences | en_US |
dc.subject.other | Cancer Research, Oncology and Pathology | en_US |
dc.title | EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Urology, University of Michigan Health System, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Urology, University of Michigan Health System, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Urology, University of Michigan Health System, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Urology, University of Michigan Health System, Ann Arbor, Michigan ; Department of Surgery, University of Michigan Health Systems, A556 MSRB II, 1500 E. Medical Center Dr, Ann Arbor, MI 48109-0654. | en_US |
dc.identifier.pmid | 19143022 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/61882/1/20903_ftp.pdf | |
dc.identifier.doi | 10.1002/pros.20903 | en_US |
dc.identifier.source | The Prostate | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.